References
- Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L, et al. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2002; 118: 1112–1119
- Fuge R, Bird J M, Fraser A, Hart D, Hunt L, Cornish J M, et al. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Haematol 2001; 113: 58–64
- Elliot M A, Nichols W L, Plumhoff E A, Ansell S M, Dispenzieri A, Gastineau D A, et al. Posttransplantation thrombotic thrombocytopenic purpura: a single experience and a contemporary review. Mayo Clin Proc 2003; 78: 421–430
- Iacopino P, Pucci G, Arcese W, Bosi A, Falda M, Locatelli F, et al. Severe thrombotic microangiopathy: An infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Bone Marrow Transplant 1999; 24: 47–51
- Roy V, Rizvi M A, Vesely S K, George J N. Thrombotic thrombocytopenic purpura purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 2001; 27: 641–646
- Daly A S, Hasegawa W S, Lipton J H, Messner H A, Kiss T L. Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver. Transfus Apheresis Sci 2002; 27: 3–12
- Busca A, Uderzo C. Bone marrow transplant associated thrombotic microangiopathy. Hematology 2000; 5: 53–67
- Chemnitz J, Fuchs M, Blau W, Hartmann P, Wickenhauser C, Scheid C, et al. Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation. Ann Hematol 2000; 79: 527–529
- Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, et al. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Bone Marrow Transplant 2004; 33: 1143–1150
- Kanamori H, Takaishi Y, Takabayashi M, Tanaka M, Yamaji S, Tomita N, et al. Clinical significance of fragmented red cells after allogeneic bone marrow transplantation. Int J Hematol 2003; 77: 180–184
- Narimatsu H, Kami M, Hara S, Matsumura T, Miyakoshi S, Kusumi E, et al. Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation. Bone Marrow Transplant 2005; 36: 517–523
- Ruggenenti P, Remuzzi G. Pathophysiology and management of thrombotic microangiopathies. J Nephrol 1998; 11: 300–310
- Teruya J, Styler M, Verde S, Topolsky, Crilley P. Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation. J Clin Apheresis 2001; 16: 169–174
- Daly A S, Xenocostas A, Lipton J H. Transplantation associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant 2002; 30: 709–715
- Corti P, Underzo C, Tagliabuc A, Della Volpe A, Annaloro C, Tagliaferri E, et al. Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation. Bone Marrow Transplant 2002; 30: 542–543